Patents by Inventor Shalini Andersson

Shalini Andersson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GLP-1 Receptor Ligand Moiety Conjugated Oligonucleotides and Uses Thereof
    Publication number: 20210346509
    Abstract: The present embodiments provide compounds and methods for targeting cells expressing GLP-1 receptor.
    Type: Application
    Filed: April 15, 2021
    Publication date: November 11, 2021
    Inventors: Brett P. Monia, Thazha P. Prakash, Garth A. KINBERGER, Richard Lee, Punit P. Seth, Shalini Andersson, Eva Carina Ämmälä, Daniel Laurent Knerr, Maria Astrid Ölwegård-Halvarsson, Eric Valeur, William John Drury, III
  • GLP-1 RECEPTOR LIGAND MOIETY CONJUGATED OLIGONUCLEOTIDES AND USES THEREOF
    Publication number: 20200268898
    Abstract: The present embodiments provide compounds and methods for targeting cells expressing GLP-1 receptor.
    Type: Application
    Filed: November 7, 2018
    Publication date: August 27, 2020
    Inventors: Brett P. MONIA, Thazha P. PRAKASH, Garth A. KINBERGER, Richard LEE, Punit P. SETH, Michael OESTERGAARD, Mehran NIKAN, Shalini ANDERSSON, Eva Carina AMMALA, Daniel Laurent KNERR, Maria OLWEGARD-HALVARSSON, William John DRURY, III, Eric VALEUR
  • GLP-1 Receptor Ligand Moiety Conjugated Oligonucleotides and Uses Thereof
    Publication number: 20190134214
    Abstract: The present embodiments provide compounds and methods for targeting cells expressing GLP-1 receptor.
    Type: Application
    Filed: May 4, 2017
    Publication date: May 9, 2019
    Inventors: Brett P. Monia, Thazha P. Prakash, Garth A. KINBERGER, Richard Lee, Punit P. Seth, Shalini Andersson, Eva Carina Ämmälä, Daniel Laurent Knerr, Maria Astrid Ölwegård-Halvarsson, Eric Valeur, William John Drury III
  • Process
    Publication number: 20050049282
    Abstract: The present invention relates to a process for the preparation of certain 2-pyridinyl)methyl]sulfinyl]-1H-benzimidazoles compounds. More specifically it relates to the preparation of an enantiomerically pure or optically enriched enantiomer of either omeprazole, pantoprazole, lansoprazole, or rabeprazole from a mixture containing the same using means for simulated moving bed chromatography.
    Type: Application
    Filed: December 17, 2002
    Publication date: March 3, 2005
    Applicant: AstraZeneca AB
    Inventors: Shalini Andersson, Markus Juza
  • Chiral adsorbents and preparation thereof as well as compounds on which the absorbents are based and preparation of the compounds
    Patent number: 6333426
    Abstract: Opticallly active adsorbents based on network polymerized derivative of dicarboxylic acids, diamines or diols which are chemically bonded to a carrier. The derivatives can be polymerized by radical polymerization or through hydrosilylation in the presence of a solid carrier. The optically active adsorbents are usable for chromatographic separation of racemic mixtures of enantiomers.
    Type: Grant
    Filed: September 28, 1999
    Date of Patent: December 25, 2001
    Assignee: EKA Nobel AB
    Inventors: Per Moller, Domingo Sanchez, Stig Allenmark, Shalini Andersson
  • Chiral adsorbents and preparation thereof as well as compounds on which the adsorbents are based and preparation of these compounds
    Patent number: 6277782
    Abstract: Optically active adsorbents based on network polymerized derivatives of dicarboxylic acids, diamines or diols which are chemically bonded to a carrier. The derivatives can be polymerized by radical polymerization or through hydrosilylation in the presence of a solid carrier. The optically active adsorbents are usable for chromatographic separation of racemic mixtures of enantiomers.
    Type: Grant
    Filed: June 26, 1995
    Date of Patent: August 21, 2001
    Assignee: Eka Nobel AB
    Inventors: Per Moller, Domingo Sanchez, Stig Allenmark, Shalini Andersson